Overview

Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia

Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
This purpose of this study is to evaluate the safety and effectiveness of Ramelteon, once daily (QD), in elderly participants with chronic insomnia.
Phase:
Phase 3
Details
Lead Sponsor:
Takeda